Unknown

Dataset Information

0

Further improvement of circuit survival in citrate based continuous renal replacement therapy.


ABSTRACT:

Background

Continuous renal replacement therapy (CRRT) is the most frequently used modality of renal replacement therapy (RRT) in critical care patients with acute kidney injury (AKI). Adequate CRRT delivery can be challenging, due to problems with circuit patency. To improve circuit patency, we developed a new CRRT protocol using continuous veno-venous hemodiafiltration (CVVHDF) with 3.0 mmol/l regional citrate anticoagulation (CVVHDF/RCA3.0) as our first choice RRT modality.

Methods

Retrospective comparison of efficacy and safety of a CVVHDF/RCA3.0 protocol with our former continuous veno-venous hemofiltration protocol with 2.2 regional citrate anticoagulation (CVVH/RCA2.2) in adult critically ill patients with AKI requiring CRRT between 25 April 2020 and 24 October 2021.

Results

In total, 56 patients (257 circuits) and 66 patients (290 circuits) were included in the CVVH/RCA2.2 and CVVHDF/RCA3.0 groups, respectively. Median circuit survival was significantly higher in patients treated with CVVHDF/RCA3.0 (39.6 (IQR 19.5-67.3) hours) compared to patients treated with CVVH/RCA2.2 (22.9 (IQR 11.3-48.6) hours) (< .001). Higher body weight and higher convective flow were associated with a lower circuit survival. Metabolic control was similar, except for metabolic alkalosis that occurred less frequently during CVVHDF/RCA3.0 (19% of patients) compared to CVVH/RCA2.2 (46% of patients) (= .006).

Conclusions

CRRT circuit survival was longer with CVVHDF/RCA3.0 compared to CVVH/RCA2.2. CRRT circuit survival was negatively associated with higher body weight and higher convective flow.

SUBMITTER: Post A 

PROVIDER: S-EPMC11292220 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Further improvement of circuit survival in citrate based continuous renal replacement therapy.

Post Alena A   Heijkoop Èmese R H ÈRH   Diebels Lotte L M LLM   Post Adrian A   van Meurs Matijs M   van der Voort Peter H J PHJ   Franssen Casper F M CFM   Volbeda Meint M  

Clinical kidney journal 20240626 8


<h4>Background</h4>Continuous renal replacement therapy (CRRT) is the most frequently used modality of renal replacement therapy (RRT) in critical care patients with acute kidney injury (AKI). Adequate CRRT delivery can be challenging, due to problems with circuit patency. To improve circuit patency, we developed a new CRRT protocol using continuous veno-venous hemodiafiltration (CVVHDF) with 3.0 mmol/l regional citrate anticoagulation (CVVHDF/RCA3.0) as our first choice RRT modality.<h4>Methods  ...[more]

Similar Datasets

| S-EPMC8890422 | biostudies-literature
| S-EPMC9968675 | biostudies-literature
| S-EPMC9540182 | biostudies-literature
| S-EPMC11781738 | biostudies-literature
| S-EPMC7906315 | biostudies-literature
| S-EPMC6939344 | biostudies-literature
| S-EPMC5549692 | biostudies-other
| S-EPMC9181744 | biostudies-literature
| S-EPMC9945286 | biostudies-literature
| S-EPMC11232640 | biostudies-literature